Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Current Report · Items 5.02 · 8-K

Allied Corp.

ALIDOTCEQUITYCurrent

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. Resignation of Chief Executive Officer On February 3, 2025 but effective January 30, 2025, Calum Hughes resigned as Chief Executive Officer and a Director of the Company. The Company wishes him well in his next position. Mr.…

Filed Feb 5, 2025Accepted Feb 5, 2025, 12:21 PM ESTCIK 1575295Accession 0001477932-25-000734
Share

Company context

Allied Corp. is a Canadian cannabis supplier with its production center in Colombia. By leveraging Canadian cannabis cultivation expertise and Colombian price advantages, Allied offers consistent supply of premium cannabis product at scale and at attractive prices, meeting international high-quality standards.

Current securities

Recent company filings

  1. 15-12G filingFeb 11, 2025
  2. 25 filingFeb 3, 2025
  3. Other EventsJan 22, 2025
  4. 10-Q filingJan 14, 2025
  5. 10-K/A filingDec 18, 2024

Disclosure sections

Items 5.02

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. Resignation of Chief Executive Officer On February 3, 2025 but effective January 30, 2025, Calum Hughes resigned as Chief Executive Officer and a Director of the Company. The Company wishes him well in his next position. Mr. Hughes was provided with a copy of the disclosures contained in this Report on Form 8-K, and has been given an opportunity to review and agree to such disclosures, and have advised that he has no objections.